USANA Health Sciences (USNA) Tops Q2 EPS by 20c
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $14.04 -0.43%
Financial Fact:
Associate incentives: 112.82M
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Associate incentives: 112.82M
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $0.74, $0.20 better than the analyst estimate of $0.54. Revenue for the quarter came in at $236 million versus the consensus estimate of $225.2 million.
GUIDANCE:
USANA Health Sciences sees FY2025 EPS of $2.35-$3.00, versus the consensus of $2.61. USANA Health Sciences sees FY2025 revenue of $920-1000 million, versus the consensus of $947 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Electra Therapeutics files for proposed IPO
- FDA approves Takeda's rusfertide for polycythemia vera treatment
- AiRWA receives Nasdaq deficiency notice over late 10-K filing
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
